Immunoassay Market to 2021 - Key Company Profile, Supply, Demand, Cost Structure, and SWOT Analysis
The major players in Immunoassay market are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens AG (Germany), Abbott Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Ortho-Clinical Diagnostics, Inc. (U.S.), and bioMérieux SA (France).
(EMAILWIRE.COM, January 15, 2019 ) Geographically, the immunoassay market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by rapidly increasing aging population and the concomitant rise in the prevalence of diseases as well as the growing life expectancy.
Get Sample Papers of Immunoassay Market spread across 204 Pages, Profiling 11 Companies and supported with 139 Tables and 44 Figures is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=269708 .
Immunoassay Market report aims to provide insights into the global market. It provides valuable information on the product & service, technology, application, end user, and region in the immunoassay market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
The immunoassay market is expected to reach USD 25.45 billion by 2021 from USD 17.16 billion in 2016 at a CAGR of 8.2%. The global immunoassay market is segmented based on product & service, technology, application, enduser, and region. The reagents & kits segment is expected to account for the largest market share of the immunoassay market during the forecast period. The high growth in this segment can be attributed to the expanding use of immunoassay tests worldwide.
Target Audience for this Report:
• In Vitro Diagnostic (IVD) Products Manufacturers
• Immunoassay Distributors and Wholesalers
• OEM (Original Equipment Manufacturers)/Contract Manufacturers
• Diagnostic Associations
• Clinical Laboratories and Hospitals
• Various Research and Consulting Firms
• Research Institutes
• Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
• Pharmaceutical and Biopharmaceutical Players
Click Here for More Information on Immunoassay Market Report Now at https://www.openpr.com/news/1464592/Immunoassay-Market-Valued-to-US-27-15-Billion-by-2024-Growth-Registered-at-6-1-CAGR.html .
Geographically, cardiac monitoring market dominated by North America due to rising incidence of cardiovascular diseases (CVDs) and rising geriatric population, followed by Europe. Market in Asia is expected to grow at highest CAGR during forecast period. This is due to significant growth in prevalence of CVD in Asian countries and increase in remote cardiac monitoring devices.
Competitive Landscape
1 Overview
2 Competitive Situation and Trends
3 Product Launches and Approvals
4 Agreements, Partnerships, and Collaborations
5 Mergers & Acquisitions
6 Expansions
Get More Information on “Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software, Services), Technique (ELISA, Rapid Test), Application (Infectious Diseases, Endocrinology, Oncology), End User (Clinical Labs, Hospitals) - Global Forecast to 2021” report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=269708 .
Research Coverage:
Growth in immunoassay market is mainly driven by factors such as rising incidence of cardiovascular disorders, growing use of mobile cardiac telemetry, and rise in private institutional nursing and home care. However, dearth of skilled healthcare professionals with expertise in electrocardiography and cardiac monitoring and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the cardiac monitoring market.
The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the immunoassay market.
Get Sample Papers of Immunoassay Market spread across 204 Pages, Profiling 11 Companies and supported with 139 Tables and 44 Figures is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=269708 .
Immunoassay Market report aims to provide insights into the global market. It provides valuable information on the product & service, technology, application, end user, and region in the immunoassay market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
The immunoassay market is expected to reach USD 25.45 billion by 2021 from USD 17.16 billion in 2016 at a CAGR of 8.2%. The global immunoassay market is segmented based on product & service, technology, application, enduser, and region. The reagents & kits segment is expected to account for the largest market share of the immunoassay market during the forecast period. The high growth in this segment can be attributed to the expanding use of immunoassay tests worldwide.
Target Audience for this Report:
• In Vitro Diagnostic (IVD) Products Manufacturers
• Immunoassay Distributors and Wholesalers
• OEM (Original Equipment Manufacturers)/Contract Manufacturers
• Diagnostic Associations
• Clinical Laboratories and Hospitals
• Various Research and Consulting Firms
• Research Institutes
• Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
• Pharmaceutical and Biopharmaceutical Players
Click Here for More Information on Immunoassay Market Report Now at https://www.openpr.com/news/1464592/Immunoassay-Market-Valued-to-US-27-15-Billion-by-2024-Growth-Registered-at-6-1-CAGR.html .
Geographically, cardiac monitoring market dominated by North America due to rising incidence of cardiovascular diseases (CVDs) and rising geriatric population, followed by Europe. Market in Asia is expected to grow at highest CAGR during forecast period. This is due to significant growth in prevalence of CVD in Asian countries and increase in remote cardiac monitoring devices.
Competitive Landscape
1 Overview
2 Competitive Situation and Trends
3 Product Launches and Approvals
4 Agreements, Partnerships, and Collaborations
5 Mergers & Acquisitions
6 Expansions
Get More Information on “Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software, Services), Technique (ELISA, Rapid Test), Application (Infectious Diseases, Endocrinology, Oncology), End User (Clinical Labs, Hospitals) - Global Forecast to 2021” report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=269708 .
Research Coverage:
Growth in immunoassay market is mainly driven by factors such as rising incidence of cardiovascular disorders, growing use of mobile cardiac telemetry, and rise in private institutional nursing and home care. However, dearth of skilled healthcare professionals with expertise in electrocardiography and cardiac monitoring and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the cardiac monitoring market.
The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the immunoassay market.
Contact Information:
ReportsnReports
Ms. Snehal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Ms. Snehal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results